FY2025 EPS Estimates for OTCMKTS:GTBIF Reduced by Analyst

Green Thumb Industries Inc. (OTCMKTS:GTBIF - Free Report) - Investment analysts at Cormark cut their FY2025 earnings per share (EPS) estimates for shares of Green Thumb Industries in a research note issued on Friday, February 28th. Cormark analyst J. Pytlak now anticipates that the company will post earnings of $0.36 per share for the year, down from their previous estimate of $0.40. The consensus estimate for Green Thumb Industries' current full-year earnings is $0.32 per share.

Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.06 by ($0.02). The business had revenue of $294.32 million for the quarter, compared to analyst estimates of $289.66 million. Green Thumb Industries had a return on equity of 3.39% and a net margin of 5.38%.

Separately, Roth Capital raised Green Thumb Industries to a "strong-buy" rating in a research note on Sunday, November 10th. Two research analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Strong Buy" and an average price target of $16.50.

Remove Ads

Green Thumb Industries Stock Down 3.5 %

Shares of OTCMKTS:GTBIF traded down $0.25 during midday trading on Monday, reaching $6.87. 259,432 shares of the company were exchanged, compared to its average volume of 492,878. The firm has a market cap of $1.46 billion, a PE ratio of 28.63 and a beta of 1.30. Green Thumb Industries has a fifty-two week low of $6.08 and a fifty-two week high of $16.33. The stock has a fifty day simple moving average of $7.29 and a two-hundred day simple moving average of $8.87.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.